Genmab — Juni 2017
-
@EL I think that really depends on when you went into the stock though. I'm somewhat comfy in middle - but I can totally understand people who came in at around 1100 and up - when that is said though, I get it why people below 7/800 ish reac in the way they do.
-
no it doesnt. These warrants were given when the stock price was at a significantly lower level, and at that price were a fair part of remuneration. It is public information how many warrants are still outstanding, so anyone buying Genmab could know what he is getting into.
-
Det er da fuldstændig ligemeget hvornår eller til hvilken kurs man er gået ind i aktien. Alle kender warrant-mekanismen. Klagepunktet (siden det nu bliver diskuteret - jeg var ikke den der tog det op i dag) er at han får for meget i løn i dag!
Uanset om det kunne forudses eller ej for 5 eller 10 år siden. -
En helt anden ting er at det jo ikke er en seriøs måde at give løn på - det nærmer sig et lotterispil, hvor nogle få er vindere. Og den ekstra lodseddel gives på en overflodsbaggrund, hvor man i forvejen har en rigelig løn. Ja, ja.. man kan da godt kalde det incitamenter.. men folk har vel deres interesser og
talenter.. uanset. Det er newspeak for: svinsk-høj-løn! -
fint nok, at du har bestemt dig for at lønpakken er for voldsom. Men beriger det virkelig os andre?
-
den bruger min bedre halvdel - flottenschmecker er et andet alias for mit første liv herinde
-
Så blev 1400 brudt nedad! Nu kan vi så styre direkte mod afgrunden
-
N
ew in ClinicalTrials: A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis - NCT03201965 - https://clinicaltrials.gov/ct2/show/NCT03201965?term=daratumumab+OR+ofatumumab&lup_s=06%2F27%2F2017&rank=1 -
der er mange gode forklaringer på faldet i dag. stor warrantudnyttelse i går, stort us fald i går - og måske ikke mindst stort fald i USDEUR (og forventet fortsat fald fra IMF)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind